 Double-blind cross-over study prostaglandin papaverine patients vasculogenic impotence Intracorporeal injection vasoactive agents treatment choice many patients organic impotence patients vasculogenic impotence respond injections papaverine papaverine/phentolamine study patients vasculogenic impotence possible prosthetic surgery total patients vasculogenic impotence intracorporeal prostaglandin micrograms intracorporeal papaverine mg double-blind fashion week Forty-six percent patients prostaglandin satisfactory erection percent patients similar response difference results McNemar test number side effects similar drugs Prostaglandin intracorporeal agent choice patients significant vasculogenic impotence